| Aggressive Non-Hodgkin Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived130 of 130show fewer |
|---|
| → investigated in trials for | Cyclophosphamidesmall molecule 119 trials (42 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 119 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 91 trials (24 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 91 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 66 trials (22 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 65 trials (20 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 65 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 60 trials (15 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 60 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 60 trials (27 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 60 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 59 trials (23 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 35 trials (10 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 33 trials (12 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 32 trials (11 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 32 trials (11 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 22 trials (8 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 19 trials (4 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 17 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 17 trials (3 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 17 trials (11 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 16 trials (9 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 15 trials (7 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 14 trials (4 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 13 trials (3 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 13 trials (4 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 13 trials (4 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 13 trials (7 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 13 trials (8 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 13 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 12 trials (4 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal antibody 9 trials (7 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mosunetuzumabmonoclonal antibody 9 trials (8 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Polatuzumab Vedotinadc 9 trials (7 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nelarabinesmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inotuzumab Ozogamicinadc 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ofatumumabmonoclonal antibody 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mogamulizumabmonoclonal antibody 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thioguaninesmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asparaginaseother 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daunorubicinsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Calaspargase Pegolother 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lisocabtagene Maraleucelgene therapy 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tafasitamabmonoclonal antibody 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axicabtagene Ciloleucelgene therapy 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Duvelisibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Loncastuximab Tesirineadc 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pirtobrutinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sugemalimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisagenlecleucelcell therapy 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vindesinesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HDAC Inhibitor REC-2282 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HyperCVAD Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idarubicinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Interferon Alfa-2bother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lomustinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | O6-Benzylguaninesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obecabtagene Autoleucelgene therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Odronextamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2bother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pidnarulexsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pixantronesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Procarbazinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tagraxofuspother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teniposidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tofacitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Treosulfansmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |